id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2015-D-2818-0022,FDA,FDA-2015-D-2818,"Rare Diseases: Common Issues in Drug Development; Draft Guidance for
Industry; Availability",Notice,Notice of Availability,2019-02-01T05:00:00Z,2019,2,2019-02-01T05:00:00Z,2019-04-03T03:59:59Z,2019-04-03T01:02:46Z,2019-00677,0,0,0900006483a32ad2
FDA-2015-D-2818-0023,FDA,FDA-2015-D-2818,"Rare Diseases: Common Issues in Drug Development; Draft Guidance for
Industry; Availability",Other,Guidance,2019-02-01T05:00:00Z,2019,2,2019-02-01T05:00:00Z,2019-04-03T03:59:59Z,2023-12-26T14:48:43Z,,0,0,0900006483a33187